ArticleThe Prostate2008

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.

Todd M Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.